Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00058240 · BASELINE

Baseline characteristics

Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma · Source last updated 2017-07-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      20
    2. group Id
      BG001
      value
      3
    3. group Id
      BG002
      value
      17
    4. group Id
      BG003
      value
      12
    5. group Id
      BG004
      value
      52
    units
    Participants
groups
  1. description
    Dose Level 1: Patients were administered Flavopiridol 30mg/m2 bolus followed by 30 mg/m2 4 hour infusion weekly for four weeks followed by two weeks without therapy for a total of 6 cycles
    id
    BG000
    title
    Dose Level 1
  2. description
    Dose Level 2: Patients were administered Flavopiridol 40mg/m2 bolus followed by 40 mg/m2 4 hour infusion weekly for four weeks followed by two weeks without therapy for a total of 6 cycles.
    id
    BG001
    title
    Dose Level 2
  3. description
    Dose Level 3: Patients were administered Flavopiridol dose level one scheduled for the first cycle. In absence of severe toxicity, dose level was escalated to 30mg/m2 bolus followed by 50 mg/m2 4 hour infusion for a total of 6 cycles
    id
    BG002
    title
    Dose Level 3
  4. description
    Dose Level 4: Patients were administered Flavopiridol dose level one scheduled for the first dose. In absence of severe toxicity, dose level was escalated to 30mg/m2 bolus followed by 50 mg/m2 4 hour infusion for a total of 6 cycles
    id
    BG003
    title
    Dose Level 4
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          44
          upper Limit
          84
          value
          61.5
        2. group Id
          BG001
          lower Limit
          44
          upper Limit
          62
          value
          52
        3. group Id
          BG002
          lower Limit
          39
          upper Limit
          69
          value
          55
        4. group Id
          BG003
          lower Limit
          38
          upper Limit
          75
          value
          60
        5. group Id
          BG004
          lower Limit
          38
          upper Limit
          84
          value
          60
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          2
        3. group Id
          BG002
          value
          3
        4. group Id
          BG003
          value
          3
        5. group Id
          BG004
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          14
        4. group Id
          BG003
          value
          9
        5. group Id
          BG004
          value
          38
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          12
        5. group Id
          BG004
          value
          52
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    patients
population Description
52 unique patients due to 6 patients being
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      20
    2. group Id
      BG001
      value
      3
    3. group Id
      BG002
      value
      17
    4. group Id
      BG003
      value
      12
    5. group Id
      BG004
      value
      52
    units
    Participants
groups
  1. description
    Dose Level 1: Patients were administered Flavopiridol 30mg/m2 bolus followed by 30 mg/m2 4 hour infusion weekly for four weeks followed by two weeks without therapy for a total of 6 cycles
    id
    BG000
    title
    Dose Level 1
  2. description
    Dose Level 2: Patients were administered Flavopiridol 40mg/m2 bolus followed by 40 mg/m2 4 hour infusion weekly for four weeks followed by two weeks without therapy for a total of 6 cycles.
    id
    BG001
    title
    Dose Level 2
  3. description
    Dose Level 3: Patients were administered Flavopiridol dose level one scheduled for the first cycle. In absence of severe toxicity, dose level was escalated to 30mg/m2 bolus followed by 50 mg/m2 4 hour infusion for a total of 6 cycles
    id
    BG002
    title
    Dose Level 3
  4. description
    Dose Level 4: Patients were administered Flavopiridol dose level one scheduled for the first dose. In absence of severe toxicity, dose level was escalated to 30mg/m2 bolus followed by 50 mg/m2 4 hour infusion for a total of 6 cycles
    id
    BG003
    title
    Dose Level 4
  5. description
    Total of all reporting groups
    id
    BG004
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          44
          upper Limit
          84
          value
          61.5
        2. group Id
          BG001
          lower Limit
          44
          upper Limit
          62
          value
          52
        3. group Id
          BG002
          lower Limit
          39
          upper Limit
          69
          value
          55
        4. group Id
          BG003
          lower Limit
          38
          upper Limit
          75
          value
          60
        5. group Id
          BG004
          lower Limit
          38
          upper Limit
          84
          value
          60
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          2
        3. group Id
          BG002
          value
          3
        4. group Id
          BG003
          value
          3
        5. group Id
          BG004
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          14
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          14
        4. group Id
          BG003
          value
          9
        5. group Id
          BG004
          value
          38
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          3
        3. group Id
          BG002
          value
          17
        4. group Id
          BG003
          value
          12
        5. group Id
          BG004
          value
          52
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    patients
population Description
52 unique patients due to 6 patients being

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice